Deerfield Management’s Elevance Health ELV Stock Holding History

Deerfield Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-53,000	Closed	-$15M	–	99
2019 Q2	$15M	Hold	53,000	–	–	0.54%	60
2019 Q1	$15.2M	Sell	53,000 -42,000	-44%	-$12.1M	0.58%	51
2018 Q4	$24.9M	Hold	95,000	–	–	1%	40
2018 Q3	$26M	Sell	95,000 -96,000	-50%	-$24.9M	0.93%	40
2018 Q2	$45.5M	Hold	191,000	–	–	1.6%	15
2018 Q1	$42M	Buy	191,000 +61,000	+47%	+$14.3M	1.45%	17
2017 Q4	$29.3M	Buy	+130,000	New	+$27.7M	1.15%	32
2017 Q3	–	Sell	-75,182	Closed	-$14.1M	–	93
2017 Q2	$14.1M	Sell	75,182 -242,818	-76%	-$43.6M	0.75%	38
2017 Q1	$52.6M	Hold	318,000	–	–	2.03%	11
2016 Q4	$45.7M	Buy	+318,000	New	+$42.6M	1.88%	16
2016 Q2	–	Sell	-102,000	Closed	-$14.2M	–	108
2016 Q1	$14.2M	Buy	102,000 +87,351	+596%	+$11.7M	0.6%	49
2015 Q4	$2.04M	Sell	14,649 -126,157	-90%	-$17.4M	0.08%	99
2015 Q3	$19.7M	Hold	140,806	–	–	0.76%	50
2015 Q2	$23.1M	Buy	140,806 +41,064	+41%	+$6.56M	0.77%	47
2015 Q1	$15.4M	Buy	+99,742	New	+$14.2M	0.5%	49

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Deerfield Management's ELV Position: Q3 2019 in Review

Deerfield Management sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 53,000 shares — an estimated $15M sold.

Deerfield Management first reported a position in ELV in Q1 2015 and held it in 15 quarters. The position peaked at $52.6M in Q1 2017. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

Deerfield Management reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
Deerfield Management sold 53,000 Elevance Health shares in Q3 2019, an estimated $15M.
Deerfield Management first reported a position in Elevance Health in Q1 2015 and held it in 15 quarters.
Deerfield Management's Elevance Health position peaked at $52.6M in Q1 2017.
1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Deerfield Management's 13F filing for Q3 2019, filed 14 Nov 2019.